Craig Venter, 79, founder of the J. Craig Venter Institute, died in San Diego after a short hospital stay related to treatment for a recently diagnosed cancer. He helped sequence the human genome and led the team that created the first bacterium with an artificial genome, advancing synthetic biology and large-scale genomic science. His rapid, entrepreneurial style provoked controversy, but his innovations and institutions left a lasting impact on biology and medicine.
Craig Venter, Genomics Pioneer Who Built the First Synthetic Bacterium, Dies at 79
FILE PHOTO - US Biologist Craig Venter attends the DLD conference in Munich. US gene researcher and medtech entrepreneur J. Craig Venter has died at 79. (zu dpa: «US pioneering gene researcher Craig Venter dead at 79») Matthias Schrader/dpa
Craig Venter, a towering figure in modern genomics and the founder of the J. Craig Venter Institute (JCVI), has died in San Diego at age 79, the institute said. He passed away following a short hospital stay after experiencing unexpected side effects from treatment for a recently diagnosed cancer.
Venter was a central force in moving genetics from slow, small-scale inquiry to a fast, data-driven science. He played a leading role in sequencing the human genome and headed the team that created the first bacterium with an artificial genome—a landmark achievement that advanced synthetic biology and sparked widespread scientific and ethical debate.
The JCVI paid tribute to Venter’s energetic approach to science and innovation. "Craig believed that science moves forward when people are willing to think differently, move decisively, and build what doesn’t yet exist," said Anders Dale, president of the JCVI, in a statement.
The institute said it will continue Venter’s mission, expanding gene research through broad partnerships and by promoting interdisciplinary teams and rapid, efficient methods—principles Venter championed throughout his career.
Career, Controversy and Legacy
Venter’s career was marked by bold ambition and rapid announcements of new projects and discoveries. His high-speed, entrepreneurial approach often drew criticism: some colleagues accused him of grandstanding and of favoring business-style promotion over cautious scientific communication. At the same time, his work won many awards and fundamentally reshaped how genomic research is done, enabling large-scale, data-intensive projects now central to biology and medicine.
Born in Salt Lake City, Utah, on October 14, 1946, Venter was the son of a bookkeeper and came from a family of German descent. He leaves a complex legacy: a pioneer who accelerated genomic science and built influential institutions, and a polarizing figure whose methods and messaging provoked intense debate within the scientific community.
The JCVI statement emphasized continuing Venter’s work through collaboration and innovation, signaling that the institute aims to carry forward both his scientific contributions and his drive to translate research into real-world applications.
Help us improve.
